心理社會因素對肺癌患者預后的影響研究進展_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

呂鵬 ^1,2 , 黃延 ¹ , 張漫雪 ¹ , 王允 ³ ,  黃頤 ¹

1. ;
2. ;
3. ;

Corresponding?author：

黃頤, Email: huangyi0421@126.com

Keywords：

DOI：

10.7507/1671-6205.202012064

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 呂鵬, 黃延, 張漫雪, 王允, 黃頤. 心理社會因素對肺癌患者預后的影響研究進展. Chinese Journal of Respiratory and Critical Care Medicine, 2021, 20(4): 294-298. doi: 10.7507/1671-6205.202012064 Copy

1.	Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health, 2018, 6(5): e555-e567.
2.	Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 313.
3.	Le L, Yu L, Guan C, et al. Epidemiology, etiology, screening, psychotherapy of malignant tumor patients with secondary depressive disorder. Curr Pharm Des, 2018, 24(22): 2591-2596.
4.	董智, 趙軍, 柳晨, 等. 肺癌骨轉移診療專家共識(2019 版). 中國肺癌雜志, 2019, 22(4): 187-207.
5.	Hovanec J, Siemiatycki J, Conway DI, et al. Lung cancer and socioeconomic status in a pooled analysis of case-control studies. PLoS One, 2018, 13(2): e0192999.
6.	Tweed EJ, Allardice GM, McLoone P, et al. Socio-economic inequalities in the incidence of four common cancers: a population-based registry study. Public Health, 2018, 154: 1-10.
7.	Martín-Sánchez JC, Bilal U, Clèries R, et al. Modelling lung cancer mortality rates from smoking prevalence: fill in the gap. Cancer Epidemiol, 2017, 49: 19-23.
8.	唐煜東, 梅小麗, 鄭娥, 等. 胸部腫瘤術后患者不良情緒現狀及影響因素分析. 中國胸心血管外科臨床雜志, 2018, 25(1): 67-70.
9.	Suh WN, Kong KA, Han Y, et al. Risk factors associated with treatment refusal in lung cancer. Thorac Cancer, 2017, 8(5): 443-450.
10.	Coleman H G, Xie Sh, Lagergren J. The epidemiology of esophageal adenocarcinoma. Gastroenterology, 2018, 154(2): 390-405.
11.	Soneji S, Tanner NT, Silvestri GA, et al. Racial and ethnic disparities in early-stage lung cancer survival. Chest, 2017, 152(3): 587-597.
12.	Murphy SE, Park SL, Balbo S, et al. Tobacco biomarkers and genetic/epigenetic analysis to investigate ethnic/racial differences in lung cancer risk among smokers. NPJ Precis Oncol, 2018, 2: 17.
13.	Brooke Steele C, Pisu M, Richardson LC. Urban/rural patterns in receipt of treatment for non–small cell lung cancer among black and white medicare beneficiaries, 2000-2003. J Natl Med Assoc, 2011, 103(8): 711-718.
14.	Van Ryn M. Research on the provider contribution to race/ethnicity disparities in medical care. Med Care, 2002, 40(1 Suppl): I140-I151.
15.	Polak M, Genowska A, Szafraniec K, et al. Area-based socio-economic inequalities in mortality from lung cancer and respiratory diseases. Int J Environ Res Public Health, 2019, 16(10): 1791.
16.	Denton EJ, Hart D, Russell PA, et al. Lung cancer and socio-economic status: inextricably linked to place of residence. Intern Med J, 2017, 47(5): 563-569.
17.	Forrest LF, Sowden S, Rubin G, et al. Socio-economic inequalities in stage at diagnosis, and in time intervals on the lung cancer pathway from first symptom to treatment: systematic review and meta-analysis. Thorax, 2017, 72(5): 430-436.
18.	Varlotto JM, Mckie K, Voland P, et al. The role of race and economic characteristics in the presentation and survival of patients with surgically resected non-small cell lung cancer. Front Oncol, 2018, 8: 146.
19.	Zheng W, Zhang H, Shen C, et al. Trend analysis of lung cancer mortality and years of life lost (YLL) rate from 1999 to 2016 in Tianjin, China: Does the lung cancer burden in rural areas exceed that of urban areas?. Thorac Cancer, 2020, 11(4): 867-874.
20.	Chen X, Zhang LW, Huang JJ, et al. Long-term exposure to urban air pollution and lung cancer mortality: a 12-year cohort study in Northern China. Sci Total Environ, 2016, 571: 855-861.
21.	Crouch E, Eberth JM, Probst JC, et al. Rural-urban differences in costs of end-of-life care for the last 6 months of life among patients with breast, lung, or colorectal cancer. J Rural Health, 2019, 35(2): 199-207.
22.	Remes O, Brayne C, Van Der Linde R, et al. A systematic review of reviews on the prevalence of anxiety disorders in adult populations. Brain Behav, 2016, 6(7): e00497.
23.	Ferrari AJ, Somerville AJ, Baxter AJ, et al. Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med, 2013, 43(3): 471-481.
24.	Gu L, Xie J, Long J, et al. Epidemiology of major depressive disorder in mainland china: a systematic review. PLoS One, 2013, 8(6): e65356.
25.	Petroulia I, Kyriakos CN, Papadakis S, et al. Patterns of tobacco use, quit attempts, readiness to quit and self-efficacy among smokers with anxiety or depression: findings among six countries of the EUREST-PLUS ITC Europe Surveys. Tob Induc Dis, 2018, 16: A9.
26.	Huang X, Zhang TZ, Li GH, et al. Prevalence and correlation of anxiety and depression on the prognosis of postoperative non-small-cell lung cancer patients in North China. Medicine (Baltimore), 2020, 99(11): e19087.
27.	Park S, Kang CH, Hwang Y, et al. Risk factors for postoperative anxiety and depression after surgical treatment for lung cancer?. Eur J Cardiothorac Surg, 2016, 49(1): e16-e21.
28.	Wang YH, Li JQ, Shi JF, et al. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies. Mol Psychiatry, 2020, 25(7): 1487-1499.
29.	L?we B, Decker O, Müller S, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care, 2008, 46(3): 266-274.
30.	王征宇, 遲玉芬. 焦慮自評量表(SAS). 上海精神醫學, 1984, (2): 73-74.
31.	Charara J, Ruel J, Lemay J, et al. Development of a flow simulator to study haemodynamic behaviour of natural and artificial blood vessels under physiologic flow conditions. J Med Eng Technol, 1999, 23(3): 83-95.
32.	Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med, 2001, 16(9): 606-613.
33.	Zung WW, Richards CB, Short MJ. Self-rating depression scale in an outpatient clinic. Further validation of the SDS. Arch Gen Psychiatry, 1965, 13(6): 508-515.
34.	Bjelland I, Dahl AA, Haug TT, et al. The validity of the Hospital Anxiety and Depression Scale. J Psychosom Res, 2002, 52(2): 69-77.
35.	肖水源. 《社會支持評定量表》的理論基礎與研究應用. 臨床精神醫學雜志, 1994, 4(2): 98-100.
36.	Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res, 2011, 20(10): 1727-1736.
37.	Aaronson N K, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst, 1993, 85(5): 365-376.
38.	劉鐵橋, 司天梅, 張朝輝, 等. 苯二氮?類藥物臨床使用專家共識. 中國藥物濫用防治雜志, 2017, 23(1): 4-6.
39.	胡昌清, 朱雪泉, 豐雷, 等. 中國抑郁障礙防治指南(第二版)解讀: 藥物治療原則. 中華精神科雜志, 2017, 50(3): 172-174.
40.	汪凱, 朱春燕, 陳海波. 綜合醫院焦慮、抑郁與軀體化癥狀診斷治療的專家共識. 中華神經科雜志, 2016, 49(12): 908-917.
41.	李金江, 龐英, 唐麗麗. 團體心理治療改善肺癌患者生活質量及情緒狀態的開放對照研究. 中國心理衛生雜志, 2014, 28(9): 657-662.
42.	Huang X, Yan A, Liu Q, et al. Effects of magnanimous therapy on coping, adjustment, and living function in advanced lung cancer. Curr Oncol (Toronto, Ont.), 2019, 26(1): e48-e56.
43.	Doering LV, Mcguire A, Eastwood JA, et al. Cognitive behavioral therapy for depression improves pain and perceived control in cardiac surgery patients. Eur J Cardiovasc Nurs, 2016, 15(6): 417-424.
44.	Davis M, Walker DL, Miles L, et al. Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology, 2010, 35(1): 105-135.
45.	Robinson OJ, Vytal K, Cornwell BR, et al. The impact of anxiety upon cognition: perspectives from human threat of shock studies. Front Hum Neurosci, 2013, 7: 203.
46.	Vodermaier A, Lucas S, Linden W, et al. Anxiety after diagnosis predicts lung cancer-specific and overall survival in patients with stage iii non-small cell lung cancer: a population-based cohort study. J Pain Symptom Manage, 2017, 53(6): 1057-1065.
47.	葉婷婷, 潘乃林. 晚期腫瘤患者與照顧者心理狀況的相關性研究. 上海護理, 2012, 12(1): 32-36.
48.	孟憲東, 高猛, 李濤, 等. 華西心情指數量表在護理人員中應用的信度與效度研究. 中國護理管理, 2017, 17(3): 310-312.
49.	Arrieta O, Angulo LP, Nú?ez-Valencia C, et al. Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Ann Surg Oncol, 2013, 20(6): 1941-1948.
50.	Polański J, Chabowski M, Chudiak A, et al. Intensity of anxiety and depression in patients with lung cancer in relation to quality of life. Adv Exp Med Biol, 2018, 1023: 29-36.
51.	Khue PM, Thom VT, Minh DQ, et al. Depression and anxiety as key factors associated with quality of life among lung cancer patients in Hai Phong, Vietnam. Front Psychiatry, 2019, 10: 352.
52.	張云霄, 李宗超, 陳冀衡, 等. 術前焦慮對胸腔鏡肺癌根治術后患者早期預后的影響. 中國肺癌雜志, 2019, 22(11): 714-718.
53.	Rahouma M, Kamel M, Abouarab A, et al. Lung cancer patients have the highest malignancy-associated suicide rate in USA:a population-based analysis. Ecancermedicalscience, 2018, 12: 859.
54.	Aboumrad M, Shiner B, Riblet N, et al. Factors contributing to cancer-related suicide: a study of root-cause analysis reports. Psychooncology, 2018, 27(9): 2237-2244.
55.	Sullivan DR, Forsberg CW, Ganzini L, et al. Depression symptom trends and health domains among lung cancer patients in the CanCORS study. Lung Cancer, 2016, 100: 102-109.
56.	Gu W, Xu YM, Zhu JH, et al. Depression and its impact on health-related quality of life among Chinese inpatients with lung cancer. Oncotarget, 2017, 8(62): 104806-104812.
57.	Yan X, Chen X, Li M, et al. Prevalence and risk factors of anxiety and depression in Chinese patients with lung cancer: a cross-sectional study. Cancer Manag Res, 2019, 11: 4347-4356.
58.	Sullivan DR, Forsberg CW, Ganzini L, et al. Longitudinal changes in depression symptoms and survival among patients with lung cancer: a national cohort assessment. J Clin Oncol, 2016, 34(33): 3984-3991.
59.	Henson KE, Brock R, Charnock J, et al. Risk of suicide after cancer diagnosis in England. JAMA Psychiatry, 2019, 76(1): 51-60.
60.	Kroenke K, Wu J, Bair MJ, et al. Reciprocal relationship between pain and depression: a 12-month longitudinal analysis in primary care. J Pain, 2011, 12(9): 964-973.
61.	Awad AG. Quality-of-life assessment in schizophrenia: the unfulfilled promise. Expert Rev Pharmacoecon Outcomes Res, 2011, 11(5): 491-493.

1. Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health, 2018, 6(5): e555-e567.
2. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 313.
3. Le L, Yu L, Guan C, et al. Epidemiology, etiology, screening, psychotherapy of malignant tumor patients with secondary depressive disorder. Curr Pharm Des, 2018, 24(22): 2591-2596.
4. 董智, 趙軍, 柳晨, 等. 肺癌骨轉移診療專家共識(2019 版). 中國肺癌雜志, 2019, 22(4): 187-207.
5. Hovanec J, Siemiatycki J, Conway DI, et al. Lung cancer and socioeconomic status in a pooled analysis of case-control studies. PLoS One, 2018, 13(2): e0192999.
6. Tweed EJ, Allardice GM, McLoone P, et al. Socio-economic inequalities in the incidence of four common cancers: a population-based registry study. Public Health, 2018, 154: 1-10.
7. Martín-Sánchez JC, Bilal U, Clèries R, et al. Modelling lung cancer mortality rates from smoking prevalence: fill in the gap. Cancer Epidemiol, 2017, 49: 19-23.
8. 唐煜東, 梅小麗, 鄭娥, 等. 胸部腫瘤術后患者不良情緒現狀及影響因素分析. 中國胸心血管外科臨床雜志, 2018, 25(1): 67-70.
9. Suh WN, Kong KA, Han Y, et al. Risk factors associated with treatment refusal in lung cancer. Thorac Cancer, 2017, 8(5): 443-450.
10. Coleman H G, Xie Sh, Lagergren J. The epidemiology of esophageal adenocarcinoma. Gastroenterology, 2018, 154(2): 390-405.
11. Soneji S, Tanner NT, Silvestri GA, et al. Racial and ethnic disparities in early-stage lung cancer survival. Chest, 2017, 152(3): 587-597.
12. Murphy SE, Park SL, Balbo S, et al. Tobacco biomarkers and genetic/epigenetic analysis to investigate ethnic/racial differences in lung cancer risk among smokers. NPJ Precis Oncol, 2018, 2: 17.
13. Brooke Steele C, Pisu M, Richardson LC. Urban/rural patterns in receipt of treatment for non–small cell lung cancer among black and white medicare beneficiaries, 2000-2003. J Natl Med Assoc, 2011, 103(8): 711-718.
14. Van Ryn M. Research on the provider contribution to race/ethnicity disparities in medical care. Med Care, 2002, 40(1 Suppl): I140-I151.
15. Polak M, Genowska A, Szafraniec K, et al. Area-based socio-economic inequalities in mortality from lung cancer and respiratory diseases. Int J Environ Res Public Health, 2019, 16(10): 1791.
16. Denton EJ, Hart D, Russell PA, et al. Lung cancer and socio-economic status: inextricably linked to place of residence. Intern Med J, 2017, 47(5): 563-569.
17. Forrest LF, Sowden S, Rubin G, et al. Socio-economic inequalities in stage at diagnosis, and in time intervals on the lung cancer pathway from first symptom to treatment: systematic review and meta-analysis. Thorax, 2017, 72(5): 430-436.
18. Varlotto JM, Mckie K, Voland P, et al. The role of race and economic characteristics in the presentation and survival of patients with surgically resected non-small cell lung cancer. Front Oncol, 2018, 8: 146.
19. Zheng W, Zhang H, Shen C, et al. Trend analysis of lung cancer mortality and years of life lost (YLL) rate from 1999 to 2016 in Tianjin, China: Does the lung cancer burden in rural areas exceed that of urban areas?. Thorac Cancer, 2020, 11(4): 867-874.
20. Chen X, Zhang LW, Huang JJ, et al. Long-term exposure to urban air pollution and lung cancer mortality: a 12-year cohort study in Northern China. Sci Total Environ, 2016, 571: 855-861.
21. Crouch E, Eberth JM, Probst JC, et al. Rural-urban differences in costs of end-of-life care for the last 6 months of life among patients with breast, lung, or colorectal cancer. J Rural Health, 2019, 35(2): 199-207.
22. Remes O, Brayne C, Van Der Linde R, et al. A systematic review of reviews on the prevalence of anxiety disorders in adult populations. Brain Behav, 2016, 6(7): e00497.
23. Ferrari AJ, Somerville AJ, Baxter AJ, et al. Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med, 2013, 43(3): 471-481.
24. Gu L, Xie J, Long J, et al. Epidemiology of major depressive disorder in mainland china: a systematic review. PLoS One, 2013, 8(6): e65356.
25. Petroulia I, Kyriakos CN, Papadakis S, et al. Patterns of tobacco use, quit attempts, readiness to quit and self-efficacy among smokers with anxiety or depression: findings among six countries of the EUREST-PLUS ITC Europe Surveys. Tob Induc Dis, 2018, 16: A9.
26. Huang X, Zhang TZ, Li GH, et al. Prevalence and correlation of anxiety and depression on the prognosis of postoperative non-small-cell lung cancer patients in North China. Medicine (Baltimore), 2020, 99(11): e19087.
27. Park S, Kang CH, Hwang Y, et al. Risk factors for postoperative anxiety and depression after surgical treatment for lung cancer?. Eur J Cardiothorac Surg, 2016, 49(1): e16-e21.
28. Wang YH, Li JQ, Shi JF, et al. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies. Mol Psychiatry, 2020, 25(7): 1487-1499.
29. L?we B, Decker O, Müller S, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care, 2008, 46(3): 266-274.
30. 王征宇, 遲玉芬. 焦慮自評量表(SAS). 上海精神醫學, 1984, (2): 73-74.
31. Charara J, Ruel J, Lemay J, et al. Development of a flow simulator to study haemodynamic behaviour of natural and artificial blood vessels under physiologic flow conditions. J Med Eng Technol, 1999, 23(3): 83-95.
32. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med, 2001, 16(9): 606-613.
33. Zung WW, Richards CB, Short MJ. Self-rating depression scale in an outpatient clinic. Further validation of the SDS. Arch Gen Psychiatry, 1965, 13(6): 508-515.
34. Bjelland I, Dahl AA, Haug TT, et al. The validity of the Hospital Anxiety and Depression Scale. J Psychosom Res, 2002, 52(2): 69-77.
35. 肖水源. 《社會支持評定量表》的理論基礎與研究應用. 臨床精神醫學雜志, 1994, 4(2): 98-100.
36. Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res, 2011, 20(10): 1727-1736.
37. Aaronson N K, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst, 1993, 85(5): 365-376.
38. 劉鐵橋, 司天梅, 張朝輝, 等. 苯二氮?類藥物臨床使用專家共識. 中國藥物濫用防治雜志, 2017, 23(1): 4-6.
39. 胡昌清, 朱雪泉, 豐雷, 等. 中國抑郁障礙防治指南(第二版)解讀: 藥物治療原則. 中華精神科雜志, 2017, 50(3): 172-174.
40. 汪凱, 朱春燕, 陳海波. 綜合醫院焦慮、抑郁與軀體化癥狀診斷治療的專家共識. 中華神經科雜志, 2016, 49(12): 908-917.
41. 李金江, 龐英, 唐麗麗. 團體心理治療改善肺癌患者生活質量及情緒狀態的開放對照研究. 中國心理衛生雜志, 2014, 28(9): 657-662.
42. Huang X, Yan A, Liu Q, et al. Effects of magnanimous therapy on coping, adjustment, and living function in advanced lung cancer. Curr Oncol (Toronto, Ont.), 2019, 26(1): e48-e56.
43. Doering LV, Mcguire A, Eastwood JA, et al. Cognitive behavioral therapy for depression improves pain and perceived control in cardiac surgery patients. Eur J Cardiovasc Nurs, 2016, 15(6): 417-424.
44. Davis M, Walker DL, Miles L, et al. Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology, 2010, 35(1): 105-135.
45. Robinson OJ, Vytal K, Cornwell BR, et al. The impact of anxiety upon cognition: perspectives from human threat of shock studies. Front Hum Neurosci, 2013, 7: 203.
46. Vodermaier A, Lucas S, Linden W, et al. Anxiety after diagnosis predicts lung cancer-specific and overall survival in patients with stage iii non-small cell lung cancer: a population-based cohort study. J Pain Symptom Manage, 2017, 53(6): 1057-1065.
47. 葉婷婷, 潘乃林. 晚期腫瘤患者與照顧者心理狀況的相關性研究. 上海護理, 2012, 12(1): 32-36.
48. 孟憲東, 高猛, 李濤, 等. 華西心情指數量表在護理人員中應用的信度與效度研究. 中國護理管理, 2017, 17(3): 310-312.
49. Arrieta O, Angulo LP, Nú?ez-Valencia C, et al. Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Ann Surg Oncol, 2013, 20(6): 1941-1948.
50. Polański J, Chabowski M, Chudiak A, et al. Intensity of anxiety and depression in patients with lung cancer in relation to quality of life. Adv Exp Med Biol, 2018, 1023: 29-36.
51. Khue PM, Thom VT, Minh DQ, et al. Depression and anxiety as key factors associated with quality of life among lung cancer patients in Hai Phong, Vietnam. Front Psychiatry, 2019, 10: 352.
52. 張云霄, 李宗超, 陳冀衡, 等. 術前焦慮對胸腔鏡肺癌根治術后患者早期預后的影響. 中國肺癌雜志, 2019, 22(11): 714-718.
53. Rahouma M, Kamel M, Abouarab A, et al. Lung cancer patients have the highest malignancy-associated suicide rate in USA:a population-based analysis. Ecancermedicalscience, 2018, 12: 859.
54. Aboumrad M, Shiner B, Riblet N, et al. Factors contributing to cancer-related suicide: a study of root-cause analysis reports. Psychooncology, 2018, 27(9): 2237-2244.
55. Sullivan DR, Forsberg CW, Ganzini L, et al. Depression symptom trends and health domains among lung cancer patients in the CanCORS study. Lung Cancer, 2016, 100: 102-109.
56. Gu W, Xu YM, Zhu JH, et al. Depression and its impact on health-related quality of life among Chinese inpatients with lung cancer. Oncotarget, 2017, 8(62): 104806-104812.
57. Yan X, Chen X, Li M, et al. Prevalence and risk factors of anxiety and depression in Chinese patients with lung cancer: a cross-sectional study. Cancer Manag Res, 2019, 11: 4347-4356.
58. Sullivan DR, Forsberg CW, Ganzini L, et al. Longitudinal changes in depression symptoms and survival among patients with lung cancer: a national cohort assessment. J Clin Oncol, 2016, 34(33): 3984-3991.
59. Henson KE, Brock R, Charnock J, et al. Risk of suicide after cancer diagnosis in England. JAMA Psychiatry, 2019, 76(1): 51-60.
60. Kroenke K, Wu J, Bair MJ, et al. Reciprocal relationship between pain and depression: a 12-month longitudinal analysis in primary care. J Pain, 2011, 12(9): 964-973.
61. Awad AG. Quality-of-life assessment in schizophrenia: the unfulfilled promise. Expert Rev Pharmacoecon Outcomes Res, 2011, 11(5): 491-493.

Previous Article
呼吸內鏡技術在慢性阻塞性肺疾病治療中的應用進展
Next Article
電子煙作為戒煙替代手段的安全性和有效性

Chinese Journal of Respiratory and Critical Care Medicine

心理社會因素對肺癌患者預后的影響研究進展

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content